Abstract Number: 905 • 2014 ACR/ARHP Annual Meeting
First Step in the Development of an Ultrasound Joint Inflammation Score for Rheumatoid Arthritis: A Data Driven Approach
Background/Purpose The use of ultrasonography (US) in rheumatoid arthritis (RA) is rapidly increasing. Currently, there is no consensus regarding which joints and tendons should be…Abstract Number: 904 • 2014 ACR/ARHP Annual Meeting
Ultrasound Synovitis Reflects Synovial Inflammation at a Histopathological Level
Background/Purpose: Ultrasound (US) is widely used by rheumatologists to assess inflammatory burden on patients with inflammatory arthritis. Some studies have shown that US measures of…Abstract Number: 903 • 2014 ACR/ARHP Annual Meeting
Poor Adherence to Medications for Systemic Lupus Erythematosus Predicts Higher Health Care Utilization in U.S. Medicaid Beneficiaries
Background/Purpose: Immunosuppressive and antimalarial drugs improve outcomes in systemic lupus erythematosus (SLE), including reducing disease activity, damage and mortality. Although prior studies have found…Abstract Number: 902 • 2014 ACR/ARHP Annual Meeting
Co-Management for Children with JIA: A Survey of Primary Care Providers Regarding Current Practices and Willingness to Provide Services
Background/Purpose: Pediatric Rheumatology (PR) is among the smallest and least geographically accessible of the pediatric subspecialties. This problem may be addressed by utilizing the more…Abstract Number: 901 • 2014 ACR/ARHP Annual Meeting
Rate of Serum Uric Acid (SUA) Assessment in Gout Patients Treated with Urate-Lowering Therapy: Treating to Target?
Background/Purpose: Gout is the most common form of inflammatory arthritis and is caused by chronic hyperuricemia, leading to urate crystal deposition disease and subsequent intermittent…Abstract Number: 900 • 2014 ACR/ARHP Annual Meeting
Race and Sex Specific Incidence Rates and Predictors of Total Knee Arthroplasty: Data from the Osteoarthritis Initiative, 7 Years Follow up
Background/Purpose: Total knee arthroplasty (TKA) is used to reduce pain and improve functional status in persons with symptomatic knee osteoarthritis (OA). Several studies point to…Abstract Number: 919 • 2014 ACR/ARHP Annual Meeting
Glucocorticoid Exposure and Fracture Risk in a Large Cohort of Commercially-Insured Rheumatoid Arthritis Patients Under Age 65
Background/Purpose Systemic glucocorticoid use can increase fracture risk, although dose-specific effects are not well understood, especially in younger adults. Underlying diseases (e.g., rheumatoid arthritis [RA])…Abstract Number: 918 • 2014 ACR/ARHP Annual Meeting
Findings from Denosumab (Prolia®) Postmarketing Safety Surveillance for Serious Infections
Background/Purpose: Prolia has marketing authorization in the EU, US, Canada, Japan, and over 40 countries or administrative districts worldwide for the treatment of postmenopausal women…Abstract Number: 917 • 2014 ACR/ARHP Annual Meeting
Evaluation of Invasive Oral Procedures and Events in Women with Postmenopausal Osteoporosis Treated with Denosumab: Results from the Pivotal Phase 3 Fracture Study Extension
Background/Purpose: Osteonecrosis of the jaw (ONJ) is a rare but serious adverse event of some antiresorptive therapies, including denosumab (DMAb), and invasive oral procedures and…Abstract Number: 916 • 2014 ACR/ARHP Annual Meeting
Effects of 2 Years of Treatment with Romosozumab Followed By 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density
Background/Purpose: We previously reported that 1 year of treatment with the sclerostin antibody romosozumab (Romo) was associated with increased bone mineral density (BMD) and bone…Abstract Number: 914 • 2014 ACR/ARHP Annual Meeting
A Predictive Model of Disease Outcome in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Serum Biomarkers
Background/Purpose: Develop predictive models of early (8 week) and late (24 week) disease outcomes using clinical features, autoantibodies, and serum biomarkers in patients with refractory…Abstract Number: 913 • 2014 ACR/ARHP Annual Meeting
Long Term Outcomes of Patients with Moderate Creatine Kinase (CK) Elevation Seen in a Rheumatology Clinic
Background/Purpose: Asymptomatic or mildly symptomatic patients with moderate creatine kinase (CK) elevation are commonly referred to rheumatologists. In patients without a clearly established diagnosis, the…Abstract Number: 915 • 2014 ACR/ARHP Annual Meeting
Increased Risk of Myocardial Infarction in Dermatomyositis and Polymyositis: A General Population-Based Cohort Study
Background/Purpose Patients with polymyositis (PM) and dermatomyositis (DM) may have an increased risk of myocardial infarction (MI), similar to other connective tissue diseases. However, no…Abstract Number: 897 • 2014 ACR/ARHP Annual Meeting
Resting State Functional Connectivity Differs Between Chronic Fatigue Syndrome Patients and Healthy Controls
Background/Purpose: Examining neural activity in the absence of task (i.e. resting state) is an active area of research. Functional connectivity, defined as correlations in BOLD…Abstract Number: 893 • 2014 ACR/ARHP Annual Meeting
Polysymptomatic Distress Categories for Clinical and Research Use
Background/Purpose: The polysymptomatic distress (PSD) scale is derived from variables used in the 2010 American College of Rheumatology (ACR) fibromyalgia (FM) criteria as modified for…
ACR Meeting Abstracts